Engrail Therapeutics logo

Engrail Therapeutics Funding & Investors

Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.

engrail.com

Total Amount Raised: $221,000,000

Engrail Therapeutics Funding Rounds

  • Series B

    $157,000,000

    Series B Investors

    F-Prime Capital
    Forbion
    Norwest Venture Partners
    RiverVest
    Eight Roads Ventures
    Longwood Fund
    Pivotal Life Sciences
    Red Tree Venture Capital.
    Ysios Capital
    Standard Life
  • Series A

    $32,000,000

    Series A Investors

    Nan Fung Life Sciences
  • Series A

    $32,000,000

    Series A Investors

    Nan Fung Life Sciences
Funding info provided by Diffbot.